期刊文献+

糖尿病对急性心肌梗死住院病死率的影响 被引量:13

Impact of diabetes mellitus on the outcomes of patients with acute myocardial infarction during hospitalization
原文传递
导出
摘要 目的:探讨糖尿病是否为影响急性心肌梗死(AMI)患者住院病死率的独立危险因素。方法:回顾分析2136例AMI患者,根据是否并发糖尿病分为2组,比较2组患者的临床特征、住院治疗和并发症发生率,并对可能影响AMI患者住院病死率的因素进行多因素回归分析。结果:与非糖尿病组相比,糖尿病组患者年龄较大[(65.5±10.3)比(62.4±11.8)岁,P<0.01],空腹血糖较高[(10.4±3.2)比(5.6±1.2)mmol/L,P<0.01],女性较多(46.4%比24.8%,P<0.01),多伴有高血压(49.9%比42.8%,P<0.01)和血脂异常(63.9%比58.7%,P<0.05),心功能≥KillipⅢ级者较多(11.3%比5.8%,P<0.01),急性期再灌注治疗率(22.3%比30.6%,P<0.01)和住院期间β受体阻滞剂的使用率(64.5%比70.6%,P<0.05)较低。糖尿病组患者住院病死率显著高于非糖尿病组(14.4%比5.9%,P<0.01)。多因素回归分析显示,年龄、高血压、糖尿病、空腹血糖、血脂异常、心功能Killip分级、再灌注治疗和β受体阻滞剂的使用率均为影响AMI患者住院病死率的独立危险因素。结论:糖尿病是影响AMI患者住院病死率的独立危险因素。 Objective:To investigate whether diabetes mellitus is an independent predictor of in hospital death in patients with acute myocardial infarction (AMI). Method: A retrospective study was carried out in 2 136 patients with AMI including 485 diabetics and 1 651 nondiahetics. Baseline characteristics, therapeutic approaches and the occurrence rate of angina pectoris, reinfarction, heart failure and death during hospitalization were compared be tween diabetic and nondiabetic patients. To identify risk factors that are predictive of in-hospital death, multivari ate logistic regression analysis was used. Result: Patients with diabetes mellitus were substantially older(E65.5 ±10.3] vs [62.4±11.8]years, P〈0.01) and exhibited a high level of fasting glucose ([10.4±3.21 vs [5.6±1.21 mmol/L, P〈0.01) than those without. Females(46.4% vs 24.8% ,P〈0.01), patients with Killip class greater than or equal to Ⅲ (11.3% vs 5.8%, P〈0.01 )were more common in diabetic than in nondiabetic patients. The prevalence of hypertension and hyperlipidemia in diabetic patients was higher than that in nondiabetic patients (49.9% vs 42.8 %, P〈0.01; 63.9% vs 58.7%, P〈0.05, respectively). Diabetic patients received reperfusion therapy including both thrombosis and primary PCI less frequently than nondiabetic patients within the first 12 hours after symptom onset (22.3% vs 30.6%,P〈0.01). Furthermore, beta receptor blockers were underused in diabetic patients during hospitalization (64.5% vs 70. 5%, P〈0.05). An increased mortality was demonstrated in diabetic patients during the hospitalization phase of AMI(14.4% vs 5.9%, P〈0.01). The results of logistic regression demonstrated that age, hypertension, diabetes mellitus, fasting glucose,hyperlipidemia, Killip class of cardiac function, and administration of reperfusion therapy and beta receptor blockers were independent predictors of in-hospital death in patients with AMI. Conclusion: Diabetes mellitus is an independent predietor of in hospital death in hospitalized patients with AMI.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2008年第12期916-918,共3页 Journal of Clinical Cardiology
基金 山东省科学技术发展重点项目(No:2002BB1CJA1)
关键词 心肌梗死 糖尿病 死亡率 Myocardial infarction Diabetes mellitus Mortality
作者简介 通讯作者:蒋世亮,E—mail:jsl—telephone@163.com
  • 相关文献

参考文献8

  • 1OTTER W, KLEYBRINK S, DOERING W, et al. Hospital outcome of acute myocardial infarction in patients with and without diabetes mellitus[J].Diabet Med,2004,21 :183-187.
  • 2高润霖.急性心肌梗死诊断和治疗指南[J].中华心血管病杂志,2001,29(12):710-725. 被引量:5093
  • 3AGUILAR D, SOLOMON S D, KφBER L, et al. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial[J]. Circulation, 2004, 21; 110: 1572-1578.
  • 4OTTER W, KI.EYBRINK S, DOERING W, et al. Hospital outcome of acute myocardial infarction in patients with and without diabetes mellitus[J]. Diabet Med, 2004,21:183-187.
  • 5KODAMA K, SAKAGASHIRA S, HORI M. Prognostic significance of diabetes mellitus in patients with acute myocardial infarction after recanalization[J]. Diabetes Res Clin Pract, 1996, 30(Suppl): 71-75.
  • 6ISHIHARA M, KAGAWA E, INOUE I, et al. Impact of admission hyperglycemia and diabetes mellitus on short-and long-term mortality after acute myocardial infarction in the coronary intervention era[J]. Am J Cardiol, 2007,15;99:1674-1679.
  • 7黎旭,刘晓惠,聂绍平,杜昕,吕强,康俊平,董建增,顾承雄,黄方炯,周玉杰,陈方,吕树铮,吴学思,马长生.糖尿病多支冠状动脉病变患者不同血管重建疗效的比较[J].临床心血管病杂志,2007,23(7):519-522. 被引量:11
  • 8BARBASH G I, REINER J, WHITE H D, et al. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytie therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO- I trial, with angiographic insights. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries[J]. J Am Coll Cardiol,1995,26:1222-1229.

二级参考文献13

  • 1肖文良,Jan Kovac.药物涂层支架在冠状动脉介入治疗中的地位和作用[J].临床心血管病杂志,2005,21(2):126-128. 被引量:5
  • 2MATHEW V,GERSH B J,WILLIAMS B A,et al.Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era:a report from the Prevention of RES tenosis with Tranilast and its Outcomes(PRESTO) trial[J].Circulation,2004,109:476-480.
  • 3KUNTZ R E.Importance of considering atherosclerosis progression when choosing a coronary revascularization strategy:the diabetes-percutaneous transluminal coronary angioplasty dilemma[J].Circulation,1999,99:847-851.
  • 4FRYE R L,BROOKS M M,NESTO R W.Gap between clinical trials and clinical practice:lessons from the Bypass Angioplasty Revascularization Investigation(BARI)[J].Circulation,2003,107:1837-1839.
  • 5MOUSSA I,LEON M B,BAIM D S,et al.Impact of sirolimus-eluting stents on outcome in diabetic patients:a SIRIUS(SIRolImUS-coated Bx Velocity balloonexpandable stent in the treatment of patients with de novo coronary artery lesions) substudy[J].Circulation,2004,109:2273-2278.
  • 6HERMILLER J B,RAIZNER A,CANNON L,et al.Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus:the TAXUS-IV trial[J].J Am Coll Cardiol,2005,45:1172-1179.
  • 7BARRETT-CONNOR E.Does hyperglycemia really cause coronary heart disease?[J].Diabetes Care,1997,20:1620-1623.
  • 8KIP K E,FAXON D P,DETRE K M,et al.Coronary angioplasty in diabetic patients.The national heart,lung,and blood institute percutaneous transluminal coronary angioplasty registry[J].Circulation,1996,94:1818-1825.
  • 9ROZENMAN Y,SAPOZNIKOV D,MOSSERI M,et al.Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus:a clue to the explanation of the results of the BARI study.Balloon angioplasty revascularization investigation[J].J Am Coll Cardiol,1997,30:1420-1425.
  • 10SOBEL B E.Altered fibrinolysis and platelet function in the development of vascular complications of diabetes[J].Curr Opin Endocrinol Diabetes,1996,3:355-360.

共引文献5102

同被引文献126

引证文献13

二级引证文献149

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部